M&A Deal Summary

MesaLabs Acquires Agena Bioscience

On September 14, 2021, MesaLabs acquired life science company Agena Bioscience from Telegraph Hill Partners for 300M USD

Acquisition Highlights
  • This is MesaLabs’ 4th transaction in the Life Science sector.
  • This is MesaLabs’ largest (disclosed) transaction.
  • This is MesaLabs’ 9th transaction in the United States.
  • This is MesaLabs’ 2nd transaction in California.

M&A Deal Summary
Date 2021-09-14
Target Agena Bioscience
Sector Life Science
Buyer(s) MesaLabs
Sellers(s) Telegraph Hill Partners
Deal Type Add-on Acquisition
Deal Value 300M USD
Advisor(s) Jefferies (Financial)
DLA Piper (Legal)

Target

Agena Bioscience

San Diego, California, United States
website
Agena Bioscience is a life science and clinical diagnostics company that offers the MassARRAY® System. The system is a highly sensitive, quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry for high-throughput genotyping and mutation profiling for cancer and other disease research, companion diagnostics, pharmacogenomics, epigenetics, clinical genetics, ag-bio genetics, and biobanking molecular sample identification. Agena Bioscience was established in 2014 and is based in San Diego, California.

Search 192,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

MesaLabs

Lakewood, Colorado, United States

website

Category Company
Founded 1982
Sector Medical Products
Employees681
Revenue 184M USD (2022)
DESCRIPTION

MesaLabs is a manufacturer and marketer of medical instruments and disposables. MesaLabs was founded in 1982 and is based in Lakewood, Colorado.

DEAL STATS #
Overall 14 of 14
Sector (Life Science) 4 of 4
Type (Add-on Acquisition) 12 of 12
State (California) 2 of 2
Country (United States) 9 of 9
Year (2021) 1 of 1
Size (of disclosed) 1 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-31 Gyros Protein Technologies AB

Uppsala, Sweden

Gyros Protein Technologies AB is a provider of peptide synthesis and bioanalytical tools for biotherapeutics discovery, development, and bioprocessing. With a large and growing installed base of instruments in the biopharmaceutical industry and related markets, Gyros Protein Technologies is leading its field in several key application areas in biotherapeutics, from research through Phase 4 clinical development and particularly in bioprocess.

Buy $180M

Seller(S) 1

SELLER

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

website

Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.

DEAL STATS #
Overall 25 of 28
Sector (Life Science) 11 of 12
Type (Add-on Acquisition) 20 of 23
State (California) 15 of 18
Country (United States) 24 of 27
Year (2021) 5 of 5
Size (of disclosed) 3 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-25 Teknova

Hollister, California, United States

Teknova is a manufacturer and sells cell culture media and buffers into the research and bioproduction markets. Teknova is based in Hollister, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-04 AltheaDx

San Diego, California, United States

AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenetics, or PGx. AltheaDx's product testing portfolio enables personalized therapeutic decisions for patients suffering from some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders, and pain. AltheaDx was founded in 1998 and is based in San Diego, California.

Sell $65M
Mergr

Product

Company

Legal